Dublin, March 27, 2019 (GLOBE NEWSWIRE) -- The "Reporter Gene Assay Market by Reagents & Assay Kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The reporter gene assays market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2018, at a CAGR of 10.1%.
Growth in this market is driven by increasing funding for cell-based research, the growing applications of gene expression, and a rising preference for cell-based assays. However, the high cost of cell biology research is expected to restrain the growth of this market to a certain extent during the forecast period.
The market is highly competitive, with numerous players competing for a larger market share. The prominent players in the global reporter gene assays market include Merck KGaA (Germany), Thermo Fisher Scientific (US), Promega Corporation (US), Abcam plc (UK), PerkinElmer (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Geno Technology (US), GeneCopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Biotium (US), and Canvax (Spain).
By end user, the academic and research institutes segment is projected to have the largest market share during the forecast period (2019-2024)
On the basis of end user, the reporter gene assays market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and contract research organizations. The academic and research institutes segment is expected to account for the largest share in 2019. The large share of this end-user segment can be attributed to the increasing government initiatives towards drug discovery and life science R&D activities.
The cell signaling segment is expected to grow at the highest CAGR during the forecast period
On the basis of application, the reporter gene assays market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. The cell signaling applications segment is expected to witness the highest CAGR owing to its importance in several cellular functionalities such as cell differentiation, cell fate determination, and cell growth, and advanced applications of cell signaling in life science sectors such as biotechnology, molecular biology, and microbiology.
APAC is projected to witness the highest growth during the forecast period
North America is expected to account for the largest share of the global reporter gene assays market in 2019. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the large population in China and India, rising geriatric population, and increasing incidence of chronic diseases. Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Break Down of Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Reporter Gene Assays: Market Overview
4.2 Reporter Gene Assays Market: Geographic Overview (2018)
4.3 Regional Mix: Reporter Gene Assays Market (2019-2024)
4.4 Reporter Gene Assays Market: Developed vs Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Funding for Cell-Based Research
5.2.1.2 Growing Applications of Gene Expression
5.2.1.3 Rising Preference for Cell-Based Assays
5.2.2 Restraint
5.2.2.1 High Cost of Cell Biology Research
5.2.3 Opportunities
5.2.3.1 Emerging Countries
5.2.3.2 Increasing Demand for Personalized Medicine
6 Reporter Gene Assays Market, By Product
6.1 Introduction
6.2 Assay Kits
6.2.1 Luciferase Assay Kits
6.2.1.1 Luciferase Assays Dominate the Assay Kits Market
6.2.2 Fluorescent Protein-Related Assay Kits
6.2.2.1 Fluorescent Reporter Proteins are Useful in Studying Cellular Events
6.2.3 Secreted Embryonic Alkaline Phosphatase Assay Kits
6.2.3.1 Advantages of Seap Assays Over Luciferase and Cat Counterparts Have Supported the Growth of This Segment
6.2.4 Chloramphenicol Acetyltransferase Assay Kits
6.2.4.1 A Cat Assay is A Standard Method for Assessing Promotor Expression in Transfected Cell Lines
6.2.5 Beta-Galactosidase Assay Kits
6.2.5.1 Ease of Use and Rapidity of These Assays Have Contributed to Their Overall Demand
6.2.6 Beta-Glucuronidase Assay Kits
6.2.6.1 Gus Reporter Assays are Mainly Used for Plant Gene Expression Research
6.2.7 Other Assay Kits
6.3 Reagents
6.3.1 Increasing Demand for High-Quality Reagents in Biosciences and Biotechnology has Driven Reagent Use
7 Reporter Gene Assays Market, By Application
7.1 Introduction
7.2 Cell Signaling Pathways
7.2.1 Cell Signaling Pathways is the Largest Application Segment of the Reporter Gene Assays: Market
7.3 Promoter Structural and Functional Analysis
7.3.1 Reporter Gene Assays Allow for the Functional Identification and Characterization of Promoter and Enhancer Elements
7.4 Gene Regulation
7.4.1 Reporter Gene Assays Acts as Powerful Tools in Analyzing Gene Regulations
7.5 Protein Interaction
7.5.1 Reporter Gene Assays are Used for the Identification and Quantitative Analysis of Protein-Protein Interaction
8 Reporter Gene Assays Market, By End User
8.1 Introduction
8.2 Academic & Research Institutes
8.2.1 Academic & Research Institutes are the Largest End Users of the Reporter Gene Assays: Market
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Increasing Number of R&D Activities to Drive the Market Growth for Pharmaceutical & Biotechnology Companies
8.4 Contract Research Organizations (CROS)
8.4.1 CROS to Provide Affordable Outlets for Companies and Academia to Pursue New Medicines
8.5 Hospital & Diagnostic Laboratories
8.5.1 High Prevalence of Chronic Diseases to Drive the Market Growth Among Hospital & Diagnostic Laboratories
9 Reporter Gene Assays Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the North American Reporter Gene Assays: Market
9.2.2 Canada
9.2.2.1 Canada to Witness the Highest Growth in the North American Market Primarily Due to the Increasing Research Activities
9.3 Europe
9.3.1 Germany
9.3.1.1 Favorable Funding Scenario to Support Market Growth in Germany
9.3.2 France
9.3.2.1 Increasing Government Investments in Proteomics & Genomics Research to Drive Market Growth
9.3.3 UK
9.3.3.1 Surge in the Prevalence of Cancer and Neurological Disorders is Driving the Adoption of Reporter Gene Assays
9.3.4 Italy
9.3.4.1 Growing Proteomics and Genomics Research to Drive the Growth of the Reporter Gene Assays: Market in Italy
9.3.5 Spain
9.3.5.1 Increasing Private and Public Funding for Cell-Based Research and the Presence of A Strong R&D Infrastructure to Drive Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China to Register the Highest Growth in the Global Reporter Gene Assays Market, Primarily Due to the Large R&D Investments in the Country
9.4.2 Japan
9.4.2.1 Increasing Incidence of Chronic Diseases and Growing Geriatric Population to Drive Market Growth
9.4.3 India
9.4.3.1 Expansion of Pharmaceutical Companies
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.5.1 Increasing Number of Proteomics and Genomics Research Activities to Support Market Growth in the Region
9.6 Middle East & Africa
9.6.1 Several Leading Global Players are Focusing on Expanding Their Presence in the MEA Region
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.2.1 Market Share Analysis: Reporter Gene Assays Market
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Situation and Trends
10.4.1 Expansions
10.4.2 Acquisitions
11 Company Profiles
11.1 Merck KGaA
11.2 Thermo Fisher Scientific Inc.
11.3 Promega Corporation
11.4 Perkinelmer
11.5 Abcam PLC
11.6 Becton, Dickinson and Company
11.7 Bio-Rad Laboratories
11.8 Danaher Corporation
11.9 Biotium
11.10 Promocell
11.11 Invivogen
11.12 Geno Technology Inc.
11.13 Genecopoeia Inc.
For more information about this report visit https://www.researchandmarkets.com/research/lb4v2j/global_reporter?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.